FI980947A0 - Ren 3R-3'R stereoisomer av zeaxantin för behandling av förändring av ögats gula fläck hos mänskor - Google Patents

Ren 3R-3'R stereoisomer av zeaxantin för behandling av förändring av ögats gula fläck hos mänskor

Info

Publication number
FI980947A0
FI980947A0 FI980947A FI980947A FI980947A0 FI 980947 A0 FI980947 A0 FI 980947A0 FI 980947 A FI980947 A FI 980947A FI 980947 A FI980947 A FI 980947A FI 980947 A0 FI980947 A0 FI 980947A0
Authority
FI
Finland
Prior art keywords
zeaxanthin
stereoisomer
pure
treatment
macular degeneration
Prior art date
Application number
FI980947A
Other languages
English (en)
Finnish (fi)
Other versions
FI980947A (sv
Inventor
Kevin M Garnett
Dennis L Gierhart
Luis H Guerrasantos
Original Assignee
Applied Food Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Publication of FI980947A0 publication Critical patent/FI980947A0/sv
Application filed by Applied Food Biotech Inc filed Critical Applied Food Biotech Inc
Publication of FI980947A publication Critical patent/FI980947A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI980947A 1995-10-31 1998-04-29 Ren 3R-3'R stereoisomer av zeaxantin för behandling av förändring av ögats gula fläck hos mänskor FI980947A (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
PCT/US1996/017563 WO1997016175A1 (en) 1995-10-31 1996-10-30 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans

Publications (2)

Publication Number Publication Date
FI980947A0 true FI980947A0 (sv) 1996-10-30
FI980947A FI980947A (sv) 1998-04-29

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980947A FI980947A (sv) 1995-10-31 1998-04-29 Ren 3R-3'R stereoisomer av zeaxantin för behandling av förändring av ögats gula fläck hos mänskor

Country Status (14)

Country Link
JP (1) JPH10512594A (sv)
KR (1) KR100570251B1 (sv)
CN (1) CN1104235C (sv)
AR (1) AR004245A1 (sv)
AU (1) AU710634B2 (sv)
BR (1) BR9611488A (sv)
CZ (1) CZ297575B6 (sv)
FI (1) FI980947A (sv)
HU (1) HU223208B1 (sv)
NO (1) NO981698L (sv)
PL (1) PL185465B1 (sv)
RU (1) RU2197958C2 (sv)
WO (1) WO1997016175A1 (sv)
ZA (1) ZA969139B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DK0534955T3 (da) * 1989-08-30 1997-10-13 Applied Food Biotech Inc Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
HUP9802314A2 (hu) 1999-04-28
PL185465B1 (pl) 2003-05-30
KR100570251B1 (ko) 2006-06-21
AU710634B2 (en) 1999-09-23
CZ130998A3 (cs) 1998-07-15
PL326558A1 (en) 1998-09-28
HUP9802314A3 (en) 1999-05-28
HU223208B1 (hu) 2004-03-29
MX9605248A (es) 1998-06-30
CN1104235C (zh) 2003-04-02
CN1201388A (zh) 1998-12-09
RU2197958C2 (ru) 2003-02-10
AU7050196A (en) 1997-05-08
ZA969139B (en) 1997-09-25
AR004245A1 (es) 1998-11-04
NO981698D0 (no) 1998-04-16
FI980947A (sv) 1998-04-29
KR19990067180A (ko) 1999-08-16
CZ297575B6 (cs) 2007-02-07
JPH10512594A (ja) 1998-12-02
BR9611488A (pt) 1999-01-19
WO1997016175A1 (en) 1997-05-09
NO981698L (no) 1998-06-08

Similar Documents

Publication Publication Date Title
ITRM940485A0 (it) Preparato oftalmico per l'uso come lacrima artificiale
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
IL117793A0 (en) Method for the treatment of macular degeneration
ITMI942365A0 (it) Retina per la chirurgia ortopedica-traumatologica
AU1709699A (en) 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
EP0820286A4 (en) TREATMENT OF EYE INFLAMMATION
AU5436198A (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
AU5258698A (en) 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
AU2467395A (en) Novel ophthalmologic uses of protein c
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
EP0791358A4 (en) REMEDY FOR OPHTHALMIC DISORDERS
FI980947A0 (sv) Ren 3R-3'R stereoisomer av zeaxantin för behandling av förändring av ögats gula fläck hos mänskor
AU1450392A (en) Small peptidic compounds useful for the treatment of glaucoma
AU2155995A (en) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU3137095A (en) Ophthalmic compositions for treating glaucoma
AU5699396A (en) Compositions for the treatment of skin conditions
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
IL121647A0 (en) Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU7985698A (en) Methods for treatment of ocular neovascularization
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
EP0769299A4 (en) AGAINST ALLERGIC DISEASES IN THE NOSE
AU6662794A (en) Composition for the treatment of impaired hair growth

Legal Events

Date Code Title Description
FD Application lapsed